Experimental treatments Ebola virus cases in the United States

there yet no fda-approved medication or vaccine. director of national institute of allergy , infectious diseases, dr. anthony fauci, has stated scientific community still in stages of understanding how infection ebola virus can treated , prevented. there no cure or specific treatment approved. however, survival improved supportive care rehydration , symptomatic treatment. treatment supportive in nature. number of experimental treatments being considered use in context of outbreak, , or undergo clinical trials.

in late august 2014, both kent brantly , nancy writebol became first people given experimental drug zmapp. both recovered, there no confirmation or proof drug factor. spanish priest ebola had taken zmapp died afterward. until time, zmapp had been tested on primates , looked promising, causing no serious side effects , protecting animals infection. bill & melinda gates foundation has donated $150,000 amgen increase production, , u.s. department of health , human services has asked number of centers increase production.

there have been @ least 2 promising treatments infected. first brincidofovir, experimental antiviral drug, given duncan, mukpo, , spencer.

treatment using transfusion of plasma ebola survivors, form of “passive immunotherapy,” since contains antibodies able fight virus, has been used apparent success on number of patients. survivor kent brantly donated blood rick sacra, ashoka mukpo , nurse nina pham. world health organization (who) has made priority try treatment, , has been telling affected countries how it.